BE893974A - Compositions pharmaceutiques contenant en association de la 6,7-dichloro-1,5-dihydroimidazo 2,1-b quinazoline-2(3h)-one et un agent anti-inflammatoire - Google Patents

Compositions pharmaceutiques contenant en association de la 6,7-dichloro-1,5-dihydroimidazo 2,1-b quinazoline-2(3h)-one et un agent anti-inflammatoire

Info

Publication number
BE893974A
BE893974A BE0/208704A BE208704A BE893974A BE 893974 A BE893974 A BE 893974A BE 0/208704 A BE0/208704 A BE 0/208704A BE 208704 A BE208704 A BE 208704A BE 893974 A BE893974 A BE 893974A
Authority
BE
Belgium
Prior art keywords
dihydroimidazo
quinazoline
dichloro
combination
pharmaceutical compositions
Prior art date
Application number
BE0/208704A
Other languages
English (en)
French (fr)
Inventor
J S Fleming
J P Buyniski
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE893974A publication Critical patent/BE893974A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE0/208704A 1981-07-30 1982-07-29 Compositions pharmaceutiques contenant en association de la 6,7-dichloro-1,5-dihydroimidazo 2,1-b quinazoline-2(3h)-one et un agent anti-inflammatoire BE893974A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/288,639 US4357330A (en) 1981-07-30 1981-07-30 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE893974A true BE893974A (fr) 1983-01-31

Family

ID=23107996

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208704A BE893974A (fr) 1981-07-30 1982-07-29 Compositions pharmaceutiques contenant en association de la 6,7-dichloro-1,5-dihydroimidazo 2,1-b quinazoline-2(3h)-one et un agent anti-inflammatoire

Country Status (12)

Country Link
US (1) US4357330A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5826817A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU559161B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE893974A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1181010A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3228402A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2510406B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2103090B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE54277B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU84306A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8800110A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA825397B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524051A1 (de) * 1985-07-05 1987-01-15 Hoechst Ag Kombinationspraeparate aus hemmstoffen der thrombozytenaggregation und deren verwendung
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
CA2171073A1 (en) * 1995-12-04 1997-06-05 Philip C. Lang Process for the preparation of ethyl-n-(2,3 dichloro-6- nitrobenzyl) glycine
AU7604400A (en) * 1999-09-21 2001-04-24 Emory University Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
US6194420B1 (en) 1999-11-30 2001-02-27 Roberts Laboratories Inc. 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof
US6388073B1 (en) 2000-07-26 2002-05-14 Shire Us Inc. Method for the manufacture of anagrelide
WO2004064841A1 (en) * 2003-01-23 2004-08-05 Shire Holdings Ag Formulation and methods for the treatment of thrombocythemia
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) * 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
CN101463035A (zh) * 2007-12-19 2009-06-24 华生制药私人有限公司 生产盐酸阿那格雷一水合物的改进方法
GB2462022B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
GB201017783D0 (en) 2010-10-21 2010-12-01 Shire Llc Process for the preparation of anagrelide and analogues thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire
US4124715A (en) 1977-05-16 1978-11-07 Jose Pozuelo Method of pharmacologically treating drug addiction with fusaric acid

Also Published As

Publication number Publication date
ZA825397B (en) 1983-06-29
AU8652782A (en) 1983-02-03
JPH0237328B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-08-23
JPS5826817A (ja) 1983-02-17
IE821828L (en) 1983-01-30
LU84306A1 (fr) 1983-04-13
MY8800110A (en) 1988-12-31
GB2103090A (en) 1983-02-16
FR2510406A1 (fr) 1983-02-04
DE3228402A1 (de) 1983-02-24
FR2510406B1 (fr) 1986-05-09
US4357330A (en) 1982-11-02
IE54277B1 (en) 1989-08-16
CA1181010A (en) 1985-01-15
DE3228402C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-01-23
AU559161B2 (en) 1987-02-26
GB2103090B (en) 1985-07-17

Similar Documents

Publication Publication Date Title
BE893974A (fr) Compositions pharmaceutiques contenant en association de la 6,7-dichloro-1,5-dihydroimidazo 2,1-b quinazoline-2(3h)-one et un agent anti-inflammatoire
IL55183A (en) 3-substituted-1,5-dihydroimidazo(2,1-b)quinazolin-2(3h)-one derivatives,their preparation and pharmaceutical compositions containing them
FR2559061B1 (fr) Compositions analgesiques et anti-inflammatoires contenant de la diphenhydramine
DE3266196D1 (en) Combined flood and spot light
MX9203040A (es) Derivados de quinona y composicion farmaceutica que los contiene.
GB2105193B (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
IT8223152A0 (it) Betaine di chinolinio di cefalosporine e relative formulazioni farmaceutiche.
DE3260051D1 (en) Benzothiazine dioxide anti-inflammatory agents, processes for their preparation, and pharmaceutical compositions containing them
ES512894A0 (es) "un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica".
BE892731A (fr) Electrodeposition de l'etain et d'alliages d'etain
EP0073819A4 (en) NASAL ADMINISTRATION OF BETA BLOCKERS AND DOSING FORMS THEREFOR.
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
IL60325A (en) 7-bromo-1,5-dihydro-3,6-dimethylimidazo(2,1-b)quinazolin-2(3h)-one isomers and tautomers and pharmaceutical preparations containing them
ES514220A0 (es) "procedimiento para la fabricacion de (tienil-2)-2 etilaminas y (tienil-3)-2 etilaminas".
NZ216386A (en) 1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-(1h)-ones and pharmaceutical compositions
DE3277171D1 (en) Pharmaceutical composition and the use of sn- or cr-protoporphyrin for the manufacture thereof
FR2508417B1 (fr) Boite de conserve avec plaque extreme pourvue d'une incision et d'une languette d'ouverture
IL66146A (en) Substituted benzylidenepyrrolo-(2,1-b)quinazolinones and pyrido-(2,1-b)quinazolinones,their preparation and pharmaceutical compositions containing them
FR2512822B1 (fr) Derives de l'antibiotique tylosine et compositions pharmaceutiques les contenant
ZA804032B (en) Pharmaceutical compositions containing benzothiazole-2(3h)-ones and use thereof
JPS57146781A (en) 1-substituted-6-n-propyl-8-methylimidazo(1,5-d)- asymmetric-triazine-4(3h)-ones and manufacture
GB2105588B (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
IT8249095A0 (it) Derivati di 4-piridilpiridazinone dotati di attivita' antiinfiammatoria ed analgesica
JPS57178046A (en) Chemical toilet and use thereof
JPS57177755A (en) Deodorizing of excretion malodorant

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ROBERTS PHARMACEUTICAL CORP.

Effective date: 20020729